Health Care & Life Sciences » Pharmaceuticals | Changchun High & New Technology Industries

Changchun High & New Technology Industries | Income Statement

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
1,968
2,179
2,312
2,796
4,000
5,276
Cost of Goods Sold (COGS) incl. D&A
410
562
544
603
762
866
Gross Income
1,557
1,617
1,768
2,192
3,238
4,409
SG&A Expense
989
1,066
1,132
1,377
2,131
2,721
EBIT
556
524
615
806
1,107
1,685
Unusual Expense
-
1
2
15
39
2
Non Operating Income/Expense
47
14
19
7
11
23
Interest Expense
11
5
5
5
6
9
Pretax Income
518
526
654
821
1,116
1,729
Income Tax
97
82
114
140
191
270
Equity in Affiliates
-
1
1
4
3
4
Consolidated Net Income
421
444
538
677
928
1,463
Net Income
284
318
384
485
662
1,006
Net Income After Extraordinaries
284
318
384
485
662
1,006
Net Income Available to Common
284
318
384
485
662
1,006
EPS (Basic)
1.88
2.11
2.55
3.08
3.89
5.92
Basic Shares Outstanding
151
151
151
157
170
170
EPS (Diluted)
1.88
2.11
2.55
2.85
3.89
5.92
Diluted Shares Outstanding
151
151
151
170
170
170
EBITDA
625
599
695
874
1,190
1,788
Other Operating Expense
12
26
21
10
1
3
Non-Operating Interest Income
6
9
19
40
65
79
Minority Interest Expense
137
126
154
192
266
456

About Changchun High & New Technology Industries

View Profile
Address
5/F, Huoju Building
Changchun Jilin 130021
China
Employees -
Website http://www.cchn.com.cn
Updated 07/08/2019
Changchun High & New Technology Industries (Group), Inc. engages in the research and development, production, and sale of biopharmaceuticals and proprietary Chinese medicines. It involves in real estate development and leasing, and property management. The company was founded in June 1993 and is headquartered in Changchun, China.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.